ANI Pharmaceuticals to Present at September Investor Conferences
ANI Pharmaceuticals will host fireside chats at three September 2026 healthcare and investment conferences, with webcasts accessible through its investor website.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ANI Pharmaceuticals (ANIP)/b) announced that President and CEO Nikhil Lalwani and members of the executive leadership team will participate in fireside chats at three September 2026 investor conferences.These are the 2026 Wells Fargo Healthcare Conference on September 10 at 1:30 p.m. ET, the Morgan Stanley 24th Annual Global Healthcare Conference on September 14 at 7:00 a.m. ET, and the H.C. Wainwright 28th Annual Global Investment Conference on September 15 at 12:00 p.m. ET. Live and archived webcasts will be available in the Investors section of the company’s website under Events and Presentations.
Details
News Market Reaction – ANIP
On Sep 3, the day this news came out, ANIP closed 1.46% below the previous close.
Data tracked by StockTitan Argus for the Sep 3 session.
Key Figures
- Wells Fargo conference date
- September 10, 2026
- 2026 Wells Fargo Healthcare Conference
- Wells Fargo conference time
- 1:30 p.m. ET
- 2026 Wells Fargo Healthcare Conference
- Morgan Stanley conference date
- September 14, 2026
- Morgan Stanley 24th Annual Global Healthcare Conference
- Morgan Stanley conference time
- 7:00 a.m. ET
- Morgan Stanley 24th Annual Global Healthcare Conference
- H.C. Wainwright conference date
- September 15, 2026
- H.C. Wainwright 28th Annual Global Investment Conference
- H.C. Wainwright conference time
- 12.00 p.m. ET
- H.C. Wainwright 28th Annual Global Investment Conference
Historical Context
-
Henry Gosebruch joined the board while director Shanmugam resigned.
-
Record quarterly revenue and reaffirmed 2026 guidance were followed by a negative reaction.
-
The company scheduled its second-quarter results discussion for August 7.
-
ANI announced its intent to appeal rulings in the CG Oncology matter.
-
SYNCHRONICITY met both co-primary endpoints with statistical significance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., Sept. 03, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team, will participate in fireside chats at the following upcoming investor conferences:
| Event | 2026 Wells Fargo Healthcare Conference |
| Date | Thursday, September 10, 2026 |
| Time | 1:30 p.m. ET |
| Webcast | Click here |
| Event | Morgan Stanley 24th Annual Global Healthcare Conference |
| Date | Monday, September 14, 2026 |
| Time | 7:00 a.m. ET |
| Webcast | Click here |
| Event | H.C. Wainwright 28th Annual Global Investment Conference |
| Date | Tuesday, September 15, 2026 |
| Time | 12.00 p.m. ET |
| Webcast | Click here |
The live and archived webcasts will also be accessible from the Company’s website at www.anipharmaceuticals.com, in the Investors section under Events and Presentations.
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit https://www.anipharmaceuticals.com.
Investor Relations:
Irina Koffler, Vice President, Investor Relations
T: 917-734-7387
E: Irina.koffler@anipharmaceuticals.com
Media Relations:
Argot Partners
T: 212-600-1494
E: ani@argotpartners.com
SOURCE: ANI Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.